Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AbbVie Reports Third-Quarter 2024 Financial Results

October 31, 2024
AbbVie Inc. (NYSE:ABBV) announced its financial results for the third quarter of 2024, showcasing impressive growth and exceeding market expectations. The pharmaceutical company reported a revenue beat of 14.4%, driven by strong sales of its flagship drugs. Additionally, AbbVie's earnings per share (EPS) surpassed estimates by 12%, demonstrating its commitment to delivering value to shareholders. The company's robust performance can be attributed to its diversified product portfolio and strategic investments in research and development. With such positive results, investors are taking notice and considering adding AbbVie stock to their portfolios. However, for a reliable forecast on the future movement of AbbVie's shares, it is recommended to consult the experts at Stocks Prognosis.

Find out how the ABBVIE INC. rate is expected to change

Get Forecast for ABBV
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for ABBV

ABBVMarch 22, 2025AbbVie ABBV Stock Moves -0.29: What You Should Know  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, has recently experienced a slight decrease in stock movement. As an investor, it is essential to keep track of such fluctuations....

ABBVMarch 20, 2025AbbVie Inc. ABBV is Experiencing Global Investor Interest: A Look into the Company's Success Story  ~2 min.

AbbVie Inc., a renowned pharmaceutical company, has been making waves in the global market, attracting significant attention from investors worldwide....

ABBVMarch 19, 2025AbbVie Inc. ABBV: A Higher-Yielding Healthcare Play That Continues to Shine  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, is steadily gaining the attention of investors. With its continuous success in the healthcare industry, AbbVie has become a top choice for hedge funds....

ABBVMarch 18, 2025The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell, and Hamilton Beach Brands  ~1 min.

According to a recent analysis by Zacks, AbbVie Inc. (ABBV) is considered one of the top healthcare stocks to invest in....

ABBVMarch 14, 2025AbbVie Inc. ABBV is Attracting Investor Attention: Here is What You Should Know  ~2 min.

AbbVie Inc. (ABBV) has been grabbing the attention of investors recently with its impressive performance in the healthcare sector....



Related news

ABBVJanuary 9, 2025AbbVie Inc. NYSE:ABBV Captivates Institutional Shareholders with 73% Ownership  ~2 min.

AbbVie Inc., the renowned pharmaceutical company listed on NYSE under the ticker symbol ABBV, boasts an impressive 73% ownership by institutional shareholders....

ABBVJanuary 10, 2025AbbVie Inc. NYSE:ABBV Shareholders Benefit from Increased Dividends  ~1 min.

AbbVie Inc., a leading pharmaceutical company, has announced that its shareholders will receive a larger dividend this year compared to the previous year....

ABBVJanuary 7, 2025AbbVie Inc. ABBV: A Promising Investment Opportunity for 2024?  ~2 min.

AbbVie Inc. (NYSE:ABBV) has been gaining attention as a trending stock lately, and for good reason....

ABBVDecember 3, 2024AbbVie Inc. Continues to Impress with Strong Financial Performance  ~1 min.

With 73% ownership in AbbVie Inc., institutional investors have a lot riding on the business, making it one of the most attractive pharmaceutical stocks to buy....

ABBVNovember 7, 2024TipRanks.com Is AbbVie NYSE:ABBV Stock a Buy After Its Dividend Hike  ~1 min.

AbbVie Inc. (ABBV) recently announced a significant increase in its dividend payout, making its stock an attractive investment. According to TipRanks....